Blood Test Detects Cancers

Blood Test to Detect Several Types of Cancer Available in US

TUSTIN, CA- A simple blood test able to detect the presence in the human body of up to 13 common cancers in their early stages will be available for sale in the United States for the first time this week on a limited basis. Clinical trials of the test -- the DR-70(tm) -- have been successfully conducted in five nations.

AMDL, Inc., developer and marketer of tests for the early detection and monitoring of cancer and other diseases, today said initial sales of the test in the United States will be restricted to hospitals and commercial and research laboratories pending approval for general marketing by the U. S. Food and Drug Administration (FDA). U.S. hospitals and laboratories will be able to purchase the test, as well as make it available to physicians and other medical institutions, under an FDA research exemption.

The test already has been approved for general marketing throughout Canada by the Health Protection Agency, the equivalent in Canada of the Food & Drug Administration in the United States.

DR-70 was developed over an 11-year period at a cost in excess of $10 million and, according to AMDL chief executive Gary L. Dreher, is the only known test able to detect several types of cancer at the same time.

"What the test does," Mr. Dreher says, "is let a person know with a high degree of specificity if he or she has one or more of the 13 most serious and most common cancers. That is the sole purpose of the test. If positive, other standard tests could be employed to determine the specific cancer."

He said the DR-70 is non-invasive, inexpensive - "at the hospital level, probably no more than $100 a test per patient" - and can be completed within a matter of hours.

The 13 cancers detectable by DR-70, Mr. Dreher says, include cancers of the lung, colon, breast, stomach, liver, rectum, ovary, esophagus, cervix, trophoblast, thyroid, malignant lymphoma and pancreas.



====================================================================== Breast Cancer News is brought to you by the The MID HUDSON OPTIONS PROJECT, INC a grassroots Breast Cancer Health Advocacy, Support and Activist Group.


FDA Clears Test:  Identify Type of Ca in Tumor Sample

FDA Press Release, July 2008


Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.